K.B. KHASANOVA¹, F.V. VALEEVA¹, T.S. YILMAZ¹, E.V. VALEEVA¹, A.A. BIKANOVA¹, L.T. BAREEVA²

 ¹Kazan State Medical University, Kazan

²Republic Clinical Hospital of the Ministry of Health of the Republic of Tatarstan, Kazan

 Contact details:

Khasanova K.B. — Assistant lecturer of the Department of Endocrinology

Address: 36 Butlerov St., Kazan, Russian Federation, 420012, tel.: +7-917-273-00-12, e-mail: kamilya_khasanova@mail.ru

ORCID: 0000-0003-1825-487X

The purpose — to study the possibility of using rs9939609 T/A polymorphisms of the FTO gene, rs5219 C/T of the KCNJ11 gene, rs1801282 C/G of the PPARG gene, rs8192678 G/A of the PPARGC1A gene, rs12255372 G/T and rs7903146 C/T of the TCF7L2 gene as markers for predicting the risk of developing type 2 diabetes mellitus in patients with T2DM risk factors.

Material and methods. 112 overweight/obese patients from the Republic of Tatarstan (79% women and 21% men) aged 22 to 79 years participated in a single–center observational cohort 3-year prospective study. All patients were clinically examined, glucose tolerance test was performed, the level of glycated hemoglobin was determined, and polymorphisms rs9939609 T/A of the FTO gene, rs5219 C/T of the KCNJ11 gene, rs1801282 C/G of the PPARG gene, rs8192678 G/A of the PPARGC1A gene, rs12255372 G/T and rs7903146 C/T of the TCF7L2 gene were studied using PCR in real-time mode. Statistical analysis was performed with R 4.1.0 software. Univariable and multivariable logistic regression modeling were performed to evaluate association between outcomes and possible predictors. Area under the ROC-curve and Nagelkerke pseudo R-squared was used to compare prognostic performance of predictors.

Results. According to the result of logistic regression (p=0.003), the carrier of the T allele KCNJ11 rs5219 is an independent risk factor for T2DM regardless of gender, age, waist circumference (WC), waist–hip ratio (WHR) and waist-to-height ratio (WHtR) and can be attributed as a marker of increased risk of T2DM. The inclusion of this polymorphism into T2DM clinical risk models, taking into account gender, age, maternal obesity, WHR and WHtR indices showed an increase of AUC from 0.74 to 0.78 (p=0.012) and from 0.73 to 0.79 (p=0.0056), respectively.

Conclusion. The rs5219 polymorphism of the KCNJ11 gene can be used as an independent marker for predicting the risk of developing type 2 diabetes mellitus. The inclusion of this polymorphism in the risk model, which takes into account, in addition to the maternal obesity, the indices of WHtR or WHR, improves its predictive ability.

Key words: type 2 diabetes, early disorders of carbohydrate metabolism, KCNJ11 gene.

 List of abbreviations

СД — diabetes mellitus; AUC (Area Under Curve) — value of area under the ROC; ИМТ — body mass index; РНУО — early disorders of carbohydrate metabolism; KCNJ11 — gene of ATF-dependent potassium channel.

REFERENCES

1. Dedov I.I., Shestakova O.K., Vikulova A.V. Epidemiological characteristics of diabetes mellitus in the Russian Federation: clinical and statistical analysis according to the data of the diabetes registry as of 01.01.2021. Sakharnyy diabet, 2021, vol. 24, no. 3, pp. 204–221 (in Russ.).
2. Buijsse B., Simmons R.K., Griffin S.J., Schulze M.B. Risk assessment tools for identifying individuals at risk of developing type 2 diabetes. Epidemiol Rev, 2011, vol. 33 (1), pp. 46–62.
3. Wray N.R., Yang J., Hayes B.J. et al. Pitfalls of predicting complex traits from SNPs. Nat Rev Genet, 2013, no. 14, pp. 507–515.
4. Khera A.V., Chaffin M., Wade K.H. et al. Polygenic Prediction of Weight and Obesity Trajectories from Birth to Adulthood. Cell, 2019, vol. 177 (3), pp. 587–596.e9.
5. Liu W., Zhuang Z., Wang W., et al. An Improved Genome-Wide Polygenic Score Model for Predicting the Risk of Type 2 Diabetes. Front Genet, 2021, vol. 12, p. 632385.
6. Valeeva F.V., Khasanova K.B., Valeeva E.V. et al. The role of the inclusion of single nucleotide polymorphisms of some genes — candidates for carbohydrate and fat metabolism in prognostic scales for the risk of developing type 2 diabetes mellitus. Aspirantskiĭ vestnik Povolzh’ya, 2023, no. 23 (1), pp. 47–56 (in Russ.).
7. Flannick J., Mercader J.M., Fuchsberger C. et al. Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls. Nature, 2019, vol. 570, pp. 71–76.
8. Hu M., Cherkaoui I., Misra S., Rutter G.A. Functional Genomics in Pancreatic β Cells: Recent Advances in Gene Deletion and Genome Editing Technologies for Diabetes Research. Front Endocrinol (Lausanne), 2020, vol. 11, p. 576632.
9. Ruchat S.M., Weisnagel S.J., Vohl M.C., et al. Evidence for interaction between PPARG Pro12Ala and PPARGC1A Gly482Ser polymorphisms in determining type 2 diabetes intermediate phenotypes in overweight subjects. Experimental and clinical endocrinology & diabetes: official journal, German Society of Endocrinology [and] German Diabetes Association, 2009, vol. 117 (9), pp. 455–459.
10. Bondar’ I.A., Shabel’nikova O.Yu. Genetic basis of type 2 diabetes mellitus. Sakharnyy diabet, 2013, no. 4, pp. 11–16 (in Russ.).
11. Dedov I.I., Shestakova M.V., Mayorov A.Yu. Algorithms of specialized medical care for patients with diabetes mellitus. Sakharnyy diabet, 2021, no. 24 (S1), pp. 19–21 (in Russ.).
12. Golagiuri. 2006 WHO/IDF Guidelines on the diagnostic criteria for diabetes and impaired glycaemic regulation. Diabet Med, 2006, vol. 23 (4), p. 570.
13. Mühlenbruch K., Jeppesen C., Joost H.G. et al. The value of genetic information for diabetes risk prediction – differences according to sex, age, family history and obesity. PLoS One, 2013, vol. 8 (5), p. e64307.
14. Henquin J.C. Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes, 2000, vol. 49 (11), pp. 1751–1760.
15. Lasram K., Ben Halim N., Hsouna S. et al. Evidence for Association of the E23K Variant of KCNJ11 Gene with Type 2 Diabetes in Tunisian Population: Population-Based Study and Meta-Analysis. Bio Med Research International, 2014.
16. Abdelhamid I., Lasram K., Meiloud G., et al. E23K variant in KCNJ11 gene is associated with susceptibility to type 2 diabetes in the Mauritanian population. Primary Care Diabetes, 2014, vol. 8 (2), pp. 171–175.
17. Florez J.C., Jablonski K.A., Kahn et al. Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program. Diabetes, 2007, vol. 56 (2), pp. 531–536.
18. Haghvirdizadeh P., Mohamed Z., Abdullah N.A. et al. KCNJ11: Genetic Polymorphisms and Risk of Diabetes Mellitus. Journal of Diabetes Research, 2015, no. 908152.
19. Wang D.D., Chen X., Yang Y., Liu, C.X. Association of Kir6.2 gene rs5219 variation with type 2 diabetes: A meta-analysis of 21,464 individuals. Primary Care Diabetes, 2018, vol. 12 (4), pp. 345–353.
20. Dimas A.S., Lagou V., Barker A. et al. Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity. Diabetes, 2014, vol. 63, pp. 2158–2171.
21. Voight B.F., Scott L.J., Steinthorsdottir V. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet, 2010, vol. 42 (7), pp. 579–589.
22. Laakso M. Biomarkers for type 2 diabetes. Mol Metab, 2019, vol. 27S, pp. S139–S146.
23. Valeeva F.V., Khasanova K.B., Ĭylmaz T.S., Mansurova R.G. Association of anthropometric parameters with the risk of developing type 2 diabetes in overweight or obese individuals: a cohort prospective study. Consilium Medicum, 2022, no. 24 (4), pp. 241–245 (in Russ.).